Small-molecule-directed mpl signaling can complement growth factors to selectively expand genetically modified cord blood cells. [electronic resource]
Producer: 20030902Description: 71-8 p. digitalISSN:- 1066-5099
- Antigens, CD34 -- biosynthesis
- Bone Marrow Cells -- chemistry
- Cell Differentiation -- drug effects
- Cell Division -- drug effects
- Cell Line
- Cells, Cultured
- Fetal Blood -- chemistry
- Genetic Vectors
- Green Fluorescent Proteins
- Growth Substances -- physiology
- Humans
- Immunomagnetic Separation -- methods
- Luminescent Proteins -- biosynthesis
- Myeloid Progenitor Cells -- drug effects
- Neoplasm Proteins -- biosynthesis
- Proto-Oncogene Proteins -- biosynthesis
- Receptors, Cytokine -- biosynthesis
- Receptors, Thrombopoietin
- Retroviridae -- genetics
- Signal Transduction -- drug effects
- Tacrolimus -- analogs & derivatives
- Transduction, Genetic
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.